PCP
Proficio Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Return
22.94%
This Quarter Return
-9.46%
1 Year Return
+22.94%
3 Year Return
+81.29%
5 Year Return
+110.28%
10 Year Return
–
AUM
$398M
AUM Growth
+$51.6M
(+15%)
Cap. Flow
+$83.9M
Cap. Flow
% of AUM
21.06%
Top 10 Holdings %
Top 10 Hldgs %
54.8%
Holding
189
New
58
Increased
75
Reduced
25
Closed
22
Top Buys
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$30.9M |
| 2 |
iShares Gold Trust
IAU
|
$27M |
| 3 |
iShares TIPS Bond ETF
TIP
|
$16.3M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$7.65M |
| 5 |
iShares Russell Mid-Cap Growth ETF
IWP
|
$5.78M |
Top Sells
Sector Composition
| 1 | Technology | 4.66% |
| 2 | Consumer Discretionary | 4.66% |
| 3 | Financials | 4.13% |
| 4 | Communication Services | 3.1% |
| 5 | Healthcare | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Danaher
DHR
$143B
| $333K | 0.08% |
+2,688
| New | +$333K |
|
102
Abbott
ABT
$231B
| $331K | 0.08% |
+3,750
| New | +$331K |
|
103
Pfizer
PFE
$141B
| $328K | 0.08% |
12,687
+1,555
| +14% | +$40.2K |
|
104
McDonald's
MCD
$224B
| $321K | 0.08% |
2,122
+928
| +78% | +$140K |
|
105
Thermo Fisher Scientific
TMO
$186B
| $318K | 0.08% |
+1,078
| New | +$318K |
|
106
Eli Lilly
LLY
$652B
| $318K | 0.08% |
+1,995
| New | +$318K |
|
107
iShares Russell 1000 ETF
IWB
$43.4B
| $317K | 0.08% |
+2,242
| New | +$317K |
|
|
IBDM
108
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
| $316K | 0.08% |
+12,580
| New | +$316K |
|
109
Lockheed Martin
LMT
$108B
| $313K | 0.08% |
+837
| New | +$313K |
|
110
Bristol-Myers Squibb
BMY
$96B
| $310K | 0.08% |
5,976
+1,859
| +45% | +$96.4K |
|
111
Fidelity National Information Services
FIS
$35.9B
| $310K | 0.08% |
2,538
+995
| +64% | +$122K |
|
112
Genco Shipping & Trading
GNK
$765M
| $310K | 0.08% |
48,282
-1,518
| -3% | -$9.75K |
|
113
Accenture
ACN
$159B
| $306K | 0.08% |
1,887
+317
| +20% | +$51.4K |
|
114
Coca-Cola
KO
$292B
| $304K | 0.08% |
8,770
+1,773
| +25% | +$61.5K |
|
115
Amgen
AMGN
$153B
| $301K | 0.08% |
1,408
+485
| +53% | +$104K |
|
116
iShares Core MSCI Emerging Markets ETF
IEMG
$103B
| $297K | 0.07% |
+229
| New | +$297K |
|
117
Vanguard Dividend Appreciation ETF
VIG
$95.8B
| $294K | 0.07% |
2,810
-1,280
| -31% | -$134K |
|
118
Medtronic
MDT
$119B
| $291K | 0.07% |
3,031
+943
| +45% | +$90.5K |
|
119
Salesforce
CRM
$239B
| $284K | 0.07% |
2,042
+627
| +44% | +$87.2K |
|
120
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $270K | 0.07% |
5,150
-943
| -15% | -$49.4K |
|
121
Gilead Sciences
GILD
$143B
| $269K | 0.07% |
+3,505
| New | +$269K |
|
122
Union Pacific
UNP
$131B
| $266K | 0.07% |
2,213
+1,097
| +98% | +$132K |
|
123
Oracle
ORCL
$654B
| $262K | 0.07% |
+5,090
| New | +$262K |
|
124
AbbVie
ABBV
$375B
| $261K | 0.07% |
+3,630
| New | +$261K |
|
125
Cigna
CI
$81.5B
| $260K | 0.07% |
+1,245
| New | +$260K |
|